
Narya Capital
Description
Narya Capital is an early-stage venture capital firm headquartered in Columbus, Ohio, co-founded by U.S. Senator J.D. Vance and seasoned venture capitalist Colin Greenspon. Established with a vision to back technology and science-driven solutions, Narya Capital distinguishes itself by primarily focusing on companies outside the traditional coastal tech hubs, particularly within the American heartland. The firm's investment thesis centers on identifying and nurturing innovative startups that address critical national needs, spanning sectors such as advanced manufacturing, defense technology, and healthcare innovation.
The firm's investment strategy is deeply rooted in supporting founders who are building foundational technologies and products, often leveraging advancements in artificial intelligence, robotics, and biotechnology. Narya Capital aims to provide not just capital but also strategic guidance and access to a robust network, helping portfolio companies scale and achieve significant impact. Their geographic focus is a deliberate effort to tap into overlooked talent pools and foster economic growth in regions historically underserved by venture capital.
Narya Capital has successfully raised two significant funds to date. Their inaugural fund, Narya Ventures I, LP, closed at $50 million in 2020, establishing their presence in the early-stage investment landscape. Building on this momentum, the firm subsequently closed its second fund, Narya Ventures II, LP, at $100 million in 2022, signaling increased capacity and ambition. With these funds, Narya Capital typically invests between $500,000 and $5 million in initial checks, targeting seed to Series A stage companies. This enables them to support a diverse range of promising ventures, from nascent ideas to those ready for significant market penetration.
Investor Profile
Narya Capital has backed more than 22 startups, with 2 new investments in the last 12 months alone. The firm has led 4 rounds, about 18% of its total and boasts 2 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Series B, Series C, Series A rounds (top funding stages).
- Majority of deals are located in United States, Canada.
- Strong thematic focus on Health Care, Artificial Intelligence (AI), Aerospace.
- Typical check size: $500K – $5M.
Stage Focus
- Series B (27%)
- Series C (23%)
- Series A (18%)
- Seed (14%)
- Series Unknown (14%)
- Series D (5%)
Country Focus
- United States (95%)
- Canada (5%)
Industry Focus
- Health Care
- Artificial Intelligence (Ai)
- Aerospace
- Machinery Manufacturing
- Military
- Elderly
- Health Insurance
- Information Technology
- Medical
- Biotechnology
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.